A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID‐19

INTRODUCTION: Hyperinflammatory state has a role in the pathogenesis of COVID‐19. Anakinra could reduce inflammation and help to combat the condition. In this study, we aimed to assess the safety and efficacy of anakinra (PerkinRA®) in severe COVID‐19. METHOD: The study was an open‐label, randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Kharazmi, Amir Behnam, Moradi, Omid, Haghighi, Mehrdad, Kouchek, Mehran, Manafi‐Rasi, Alireza, Raoufi, Masoomeh, Shoaei, ‪Simin Dokht, Hadavand, Fahimeh, Nabavi, Mahmood, Miri, Mir Mohammad, Salarian, Sara, Shojaei, Seyedpouzhia, Khalili, Shayesteh, Sistanizad, Mohammad, Sadeghi, Setayesh, Karagah, Amirhossein, Asgari, Saemeh, Jaffaraghaei, Morteza, Araghi, Shahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652881/
https://www.ncbi.nlm.nih.gov/pubmed/34762351
http://dx.doi.org/10.1002/iid3.563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652881/
https://www.ncbi.nlm.nih.gov/pubmed/34762351
http://dx.doi.org/10.1002/iid3.563

Ejemplares similares